MX2024007588A - Composiciones de liposomas de oxazolidinona. - Google Patents

Composiciones de liposomas de oxazolidinona.

Info

Publication number
MX2024007588A
MX2024007588A MX2024007588A MX2024007588A MX2024007588A MX 2024007588 A MX2024007588 A MX 2024007588A MX 2024007588 A MX2024007588 A MX 2024007588A MX 2024007588 A MX2024007588 A MX 2024007588A MX 2024007588 A MX2024007588 A MX 2024007588A
Authority
MX
Mexico
Prior art keywords
oxazolidinone
liposome compositions
compositions
liposome
regard
Prior art date
Application number
MX2024007588A
Other languages
English (en)
Spanish (es)
Inventor
Dmitri B Kirpotin
Daryl C Drummond
Alexander Koshkaryev
Charles O Noble
Original Assignee
Akagera Medicines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akagera Medicines Inc filed Critical Akagera Medicines Inc
Publication of MX2024007588A publication Critical patent/MX2024007588A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2024007588A 2021-12-22 2022-12-22 Composiciones de liposomas de oxazolidinona. MX2024007588A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163292899P 2021-12-22 2021-12-22
PCT/US2022/082290 WO2023122759A2 (en) 2021-12-22 2022-12-22 Oxazolidinone liposome compositions

Publications (1)

Publication Number Publication Date
MX2024007588A true MX2024007588A (es) 2024-07-09

Family

ID=86903807

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024007588A MX2024007588A (es) 2021-12-22 2022-12-22 Composiciones de liposomas de oxazolidinona.

Country Status (12)

Country Link
US (2) US20250064739A1 (cg-RX-API-DMAC7.html)
EP (1) EP4452252A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025501769A (cg-RX-API-DMAC7.html)
KR (1) KR20240152302A (cg-RX-API-DMAC7.html)
CN (1) CN118900689A (cg-RX-API-DMAC7.html)
AR (1) AR128071A1 (cg-RX-API-DMAC7.html)
AU (1) AU2022420614A1 (cg-RX-API-DMAC7.html)
CA (1) CA3241952A1 (cg-RX-API-DMAC7.html)
IL (1) IL313709A (cg-RX-API-DMAC7.html)
MX (1) MX2024007588A (cg-RX-API-DMAC7.html)
WO (1) WO2023122759A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA202404799B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102859152B1 (ko) * 2024-10-24 2025-09-12 주식회사 한국리포좀 합성 지질 리포좀 기반의 일본 뇌염 바이러스 백신 및 그의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180134B1 (en) * 1993-03-23 2001-01-30 Sequus Pharmaceuticals, Inc. Enhanced ciruclation effector composition and method
TWI378092B (en) * 2003-06-03 2012-12-01 Rib X Pharmaceuticals Inc Biaryl heterocyclic compounds and methods of making and using the same
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
US8658203B2 (en) * 2004-05-03 2014-02-25 Merrimack Pharmaceuticals, Inc. Liposomes useful for drug delivery to the brain
WO2007005754A2 (en) * 2005-07-01 2007-01-11 Alza Corporation Liposomal delivery vehicle for hydrophobic drugs
US20180344644A1 (en) * 2015-09-21 2018-12-06 Mallinckrodt Llc Improved stability of liposome formulations and uses thereof
AU2021292747A1 (en) * 2020-06-18 2023-02-23 Akagera Medicines, Inc. Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof

Also Published As

Publication number Publication date
AU2022420614A1 (en) 2024-06-27
US20260083674A1 (en) 2026-03-26
EP4452252A2 (en) 2024-10-30
EP4452252A4 (en) 2025-12-03
KR20240152302A (ko) 2024-10-21
WO2023122759A3 (en) 2023-08-31
IL313709A (en) 2024-08-01
US20250064739A1 (en) 2025-02-27
JP2025501769A (ja) 2025-01-23
WO2023122759A2 (en) 2023-06-29
CN118900689A (zh) 2024-11-05
AR128071A1 (es) 2024-03-20
CA3241952A1 (en) 2023-06-29
ZA202404799B (en) 2025-12-17

Similar Documents

Publication Publication Date Title
PE20190977A1 (es) Compuestos de 7-feniletilamino-4h-pirimido [4,5-d][1,3]-oxazin-2-ona como inhibidores de idh1 e ihd2 mutantes
UY36897A (es) Composiciones inoculantes estables y métodos para su producción
MY180554A (en) Carbodiimide-based aqueous resin crosslinking agent
WO2022217123A3 (en) Combination therapies with cbl-b inhibitor compounds
HK1212207A1 (en) Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
MX336191B (es) Derivados de carbamato de hexafluoroisopropilo, su preparacion y su uso en terapeutica.
HK1245302A1 (zh) 载体分子组合物及相关方法
ZA202404799B (en) Oxazolidinone liposome compositions
MX395263B (es) Forma cristalina de base libre de lorlatinib
RU2014137471A (ru) Азеотропоподобные композиции на основе z-1, 1, 1, 4, 4, 4-гексафтор-2-бутена и их применение
MX2023012325A (es) Anticuerpos anti-tslp modificados.
MX2021003427A (es) Nuevos oxadiazoles.
SA518400042B1 (ar) مترافق من فيناستيريد مع ببتيد
CR7765A (es) Queso crema bajo en proteina
MX2021008983A (es) Atributos de aflibercept y metodos de caracterizacion y modificacion de los mismos.
MX385179B (es) Una composicion no nematicida y uso de los mismos.
MX2021003163A (es) Metodo para incrementar la estabilidad durante el almacenamiento de las esporas fungicas.
PH12019500345A1 (en) Conjugate of minoxidil and peptide
MX2024015561A (es) Composicion de alulosa con estabilidad excelente
KR102598627B9 (ko) 안정성이 향상된 아스타잔틴 용액의 제조방법과 이를 포함하는 화장료 조성물
WO2019039805A3 (ko) 2차 전지용 전해질 조성물 및 이를 포함하는 2차 전지
MX2023009000A (es) Composiciones agroquímicas y sus métodos de fabricación y uso.
AR106715A1 (es) Composiciones inoculantes estables y métodos para su producción
WO2015001524A3 (en) Stabilization of rose dedifferentiated cells
WO2019022994A8 (en) Biomass fuel pellets incorporating wax compositions